1st Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Shortage of prescription drugs - Supported and tracked legislative efforts (S. 296, H.R 2245, Energy and Commerce and HELP Committee draft legislation) to mitigate ongoing issue with prescription drug shortages. Hospital Group Purchasing - Engaged in education and outreach efforts on hospital group purchasing organization and the role of GPOs play in the health care marketplace. Tracked implementation of transparancy efforts included under the Affordable Care Act. Unique Device Identification - Advocated for the release of regulations developing a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. Endorsed legislation (S. 2193) that would require the FDA to issue such regulations by the end of 2012. 340 B (of the Public Health Services Act) Drug Discount Program - Monitored Congressional investigation into the 340 B drug discount program. Tracked legislative proposals to expand the program to inpatient hospitals. Independent Payment Advisory Board - Supported legislation (S. 668, H.R. 452) to repeal the Independent Payment Advisory Board. Tracked legislative efforts (H.R. 5) to repeal IPAB and make changes to medical malpractice laws. Conducted outreach and education efforts with policymakers on initiatives being offered by VHA to improve hospital clinical performance.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: Food & Drug Administration (FDA); SENATE; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 452 (112th), S. 2193 (112th), H.R. 5 (112th), S. 668 (112th), H.R. 2245 (112th), S. 296 (112th)

Taxation/Internal Revenue Code TAX

Not-for-profit hospital tax exemption - monitored the implementation of new requirements under the Affordable Care Act for not-for-profit, tax exempt hospitals. Advocated for manageable requirements for hospitals in completing the IRS Form 990 Schedule H. Tracked development of requirements that hospitals conduct community health needs assessments.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Internal Revenue Service (IRS)

Medicare/Medicaid MMM

Medicare Physician Payment - Supported extension of current Medicare physician payment levels while opposing the inclusion of cuts to hospital payments in legislation (H.R. 3630) to adjust Medicare payment rates for physicians. House FY 2013 Budget Resolution - Monitored proposals included in budget that would make substantial changes to the Medicare and Medicaid programs.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: Food & Drug Administration (FDA); SENATE; Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3630 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.